health
Transforming Lives with Targeted Neurotherapeutics
Xylo is pioneering next-generation therapeutics designed to rewire neural circuits and restore brain function.
Xylo combines advanced neuroscience with computational drug discovery to develop optimized treatments for neurological and psychiatric conditions. The company builds a pipeline of therapies designed to enhance neuroplasticity and address critical gaps in treatment, delivering breakthrough therapies for unmet patient needs worldwide.
Product
Reimagining Neurotherapeutics
XYLO's computationally enhanced platform combines neuroscience with computational drug discovery for revolutionary care in neurological and psychiatric conditions, enhancing neuroplasticity and addressing critical treatment gaps.